• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名使用甲氨蝶呤和阿达木单抗治疗的类风湿关节炎患者发生舌部结核。

Tuberculosis of the tongue in a patient with rheumatoid arthritis treated with methotrexate and adalimumab.

作者信息

Assante Luca Rosario, Barra Enrica, Bocchino Marialuisa, Zuccarini Giacomo, Ferrara Gerardo, Sanduzzi Alessandro

机构信息

Section of Respiratory Diseases, Department of Surgery and Clinical Medicine, University Federico II, Naples; Unit of Pathology, AORN Ospedali dei Colli, Naples, Italy; Unit of Pathology, AO G. Rummo, Benevento, Italy.

出版信息

Infez Med. 2014 Jun;22(2):144-8.

PMID:24955803
Abstract

In recent years Tumor Necrosis Factor alpha (TNF alfa) inhibitors have been highly effective in treating rheumatoid arthritis (RA). However, patients receiving these inhibitors have an increased risk of developing tuberculosis (TB). We describe a rare case of tuberculosis of the tongue in an RA patient treated with methotrexate (MTX) and the TNF alfa inhibitor adalimumab (ADA) for the previous six years. Pretreatment tuberculin skin test (TST) was negative. The patient was admitted to our division complaining of a sore throat for months. Clinical examination revealed a swollen non-healing ulcer at the base of the tongue, which was suspected to be a squamous cell carcinoma. Histopathological assessment unexpectedly revealed a chronic granulomatous inflammation compatible with tuberculosis. TST was strongly positive and the T Spot TB test was also reactive. MTX and ADA were discontinued and the patient received antituberculous treatment with complete healing of the lesion. After three months our patient had a worsening RA that was treated with MTX and rituximab with no TB related adverse events. This case highlights the importance of considering tuberculosis in the differential diagnosis of ulcerative lesions of the oral cavity, especially in immunocompromised patients treated with TNF alfa inhibitors. Rituximab can be a valid alternative therapy in such patients.

摘要

近年来,肿瘤坏死因子α(TNFα)抑制剂在治疗类风湿性关节炎(RA)方面疗效显著。然而,接受这些抑制剂治疗的患者患结核病(TB)的风险增加。我们描述了一例罕见的舌部结核病例,该患者为一名类风湿性关节炎患者,此前六年一直使用甲氨蝶呤(MTX)和TNFα抑制剂阿达木单抗(ADA)进行治疗。治疗前结核菌素皮肤试验(TST)为阴性。该患者因数月来咽痛而入住我科。临床检查发现舌根部有一个肿胀且不愈合的溃疡,怀疑为鳞状细胞癌。组织病理学评估意外发现为与结核病相符的慢性肉芽肿性炎症。TST呈强阳性,T-SPOT.TB检测也呈阳性反应。停用MTX和ADA,患者接受抗结核治疗,病变完全愈合。三个月后,我们的患者类风湿性关节炎病情恶化,接受了MTX和利妥昔单抗治疗,未出现与结核相关的不良事件。该病例凸显了在口腔溃疡性病变的鉴别诊断中考虑结核病的重要性,尤其是在接受TNFα抑制剂治疗的免疫功能低下患者中。利妥昔单抗可能是这类患者的一种有效替代疗法。

相似文献

1
Tuberculosis of the tongue in a patient with rheumatoid arthritis treated with methotrexate and adalimumab.一名使用甲氨蝶呤和阿达木单抗治疗的类风湿关节炎患者发生舌部结核。
Infez Med. 2014 Jun;22(2):144-8.
2
Oral tuberculosis in a patient with rheumatoid arthritis after long treatment with methotrexate and adalimumab.类风湿关节炎患者在接受甲氨蝶呤和阿达木单抗长期治疗后发生口腔结核。
J Clin Rheumatol. 2010 Oct;16(7):330-1. doi: 10.1097/RHU.0b013e3181f3c003.
3
Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: results from a randomized controlled trial.利妥昔单抗联合肿瘤坏死因子抑制剂和甲氨蝶呤治疗活动性类风湿关节炎患者的安全性评估:一项随机对照试验的结果
Arthritis Rheum. 2011 Mar;63(3):622-32. doi: 10.1002/art.30194.
4
Lingual tuberculosis.舌结核
Indian J Tuberc. 2012 Jan;59(1):39-41.
5
Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial.早期类风湿关节炎患者在基于甲氨蝶呤的达标治疗策略中加用或不加用阿达木单抗时手部骨质流失情况——早期类风湿关节炎优化治疗算法(OPERA)试验的一项子研究
Clin Rheumatol. 2017 Apr;36(4):781-789. doi: 10.1007/s10067-016-3489-1. Epub 2016 Dec 5.
6
The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.PREMIER研究:一项多中心、随机、双盲临床试验,对比阿达木单抗联合甲氨蝶呤与单用甲氨蝶呤或单用阿达木单抗治疗早期侵袭性类风湿关节炎且既往未接受过甲氨蝶呤治疗的患者。
Arthritis Rheum. 2006 Jan;54(1):26-37. doi: 10.1002/art.21519.
7
Impact of methotrexate dose on efficacy of adalimumab in Japanese patients with rheumatoid arthritis: Results from registered data analyses.甲氨蝶呤剂量对日本类风湿关节炎患者阿达木单抗疗效的影响:注册数据分析结果
Mod Rheumatol. 2017 Jan;27(1):15-21. doi: 10.3109/14397595.2016.1170958. Epub 2016 May 4.
8
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial.在接受甲氨蝶呤联合治疗的活动性类风湿关节炎患者中,使用阿达木单抗(一种人抗肿瘤坏死因子单克隆抗体)治疗的影像学、临床及功能转归:一项随机、安慰剂对照、为期52周的试验。
Arthritis Rheum. 2004 May;50(5):1400-11. doi: 10.1002/art.20217.
9
[Lingual tuberculosis revealing disseminated tuberculosis].[舌结核揭示播散性结核]
Rev Med Interne. 2007 Feb;28(2):124-6. doi: 10.1016/j.revmed.2006.11.009. Epub 2006 Nov 27.
10
Time lag between the initiation of adalimumab after methotrexate correlates with the efficacy of adalimumab in rheumatoid arthritis patients.甲氨蝶呤之后开始使用阿达木单抗的时间间隔与阿达木单抗在类风湿关节炎患者中的疗效相关。
Mod Rheumatol. 2016 Sep;26(5):676-80. doi: 10.3109/14397595.2015.1132952. Epub 2016 Feb 16.

引用本文的文献

1
Extrapulmonary Tuberculosis: An Otorhinolaryngologist's Perspective.肺外结核病:耳鼻咽喉科医生的视角
Indian J Otolaryngol Head Neck Surg. 2022 Dec;74(Suppl 3):5562-5568. doi: 10.1007/s12070-021-02903-3. Epub 2021 Oct 8.
2
World Workshop on Oral Medicine VII: Oral adverse effects to biologic agents in patients with inflammatory disorders. A scoping review.第七届世界口腔医学研讨会:炎症性疾病患者生物制剂的口腔不良反应。一项范围综述。
J Oral Pathol Med. 2023 Jan;52(1):1-8. doi: 10.1111/jop.13389. Epub 2022 Dec 13.
3
Angioedema, ACE inhibitor and COVID-19.
血管性水肿、血管紧张素转换酶抑制剂与2019冠状病毒病
BMJ Case Rep. 2020 Sep 9;13(9):e237888. doi: 10.1136/bcr-2020-237888.
4
Disseminated tuberculosis caused by presenting as a tongue base mass.以舌根肿物形式出现的播散性结核病。
BMJ Case Rep. 2018 Oct 14;2018:bcr-2018-225436. doi: 10.1136/bcr-2018-225436.